Speaker Spotlight: Mohit Shrivastava to Present Lab 5.0 Market Forecast at analytica Lab India 2026

Hyderabad, India, September 2026 — Mohit Shrivastava, AVP – Research & Consulting at Coherent Market Insights (CMI), will take the stage at analytica Lab India 2026 on September 11 to present a session addressing a question that is becoming increasingly difficult to answer with a single number: how deeply have automation and artificial intelligence (AI) penetrated India's laboratories, and how much of that progress is already happening versus what is still anticipated?

Scheduled from 20 PM to 2:30 PM in Hall 5, the session, titled "Lab 5.0 in India: Laboratory Automation, Informatics and AI Market Opportunity, 2026–2033," is based on CMI's new market intelligence report. analytica Lab India 2026 The report has been developed specifically for the analytica Lab India 2026 audience, which includes laboratory administrators, instrumentation providers, informatics vendors, and investors evaluating where to invest next in digital laboratory infrastructure.

Lab 5.0 adoption is not progressing at the same pace across India's laboratory ecosystem. A pharmaceutical quality control laboratory in an established manufacturing hub may already be using integrated LIMS and automated sample handling, while a comparable research facility elsewhere may still be in the process of digitizing basic record-keeping. Similarly, AI adoption in analytical instrumentation is advancing considerably faster than the use of AI in everyday laboratory operations.


Shrivastava's session will examine this uneven adoption landscape, exploring where different types of laboratories stand today, why adoption varies significantly across facilities and regions, and what these differences mean for India's transition toward Lab 5.0.

https://analyticalabindia.com/en/trade-fair/

https://www.coherentmarketinsi........ghts.com/press-r

Coherent Market Insights Brings Market Intelligence to analytica Lab India 2026 as Knowledge Partner

India’s laboratory and analytical technology landscape is undergoing significant transformation, supported by the growth of pharmaceutical manufacturing, biotechnology, advanced diagnostics, and laboratory automation. With AI and digital technologies becoming increasingly important, industry stakeholders are looking for reliable insights to understand emerging opportunities and market trends.

In line with these developments, Coherent Market Insights (CMI) has been named Knowledge Partner for Analytica Lab India 2026, a leading exhibition focused on laboratory technology, analytical solutions, biotechnology, and diagnostics.

Organized by Messe Muenchen India Pvt. Ltd., analytica Lab India 2026 will be held from September 10–12, 2026, at the HITEX Exhibition Centre in Hyderabad. The event is expected to bring together laboratory professionals, researchers, manufacturers, technology providers, and industry decision-makers from across the sector.

Analytica Lab India- https://analyticalabindia.com/en/

Coherent Market Insights -https://www.coherentmarketinsi....ghts.com/press-relea

Hydrocephalus Shunts Market Size and Growth Outlook 2026-2033

The hydrocephalus shunts industry is witnessing steady expansion driven by advancements in medical technologies and rising prevalence of cerebrospinal fluid disorders. This niche sector's market dynamics reveal promising market growth supported by innovative solutions and growing healthcare infrastructure worldwide.

Market Size and Overview

The hydrocephalus shunts market is estimated to be valued at USD 371.4 Mn in 2025 and is expected to reach USD 543.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

https://www.coherentmi.com/ind....ustry-reports/hydroc

Hereditary Amyloidosis Market: Size, Trends, and Growth Outlook 2026-2033

The hereditary amyloidosis market is rapidly evolving as novel therapies and diagnostic tools gain traction globally. Increasing disease awareness and enhanced genetic testing capabilities have intensified market demand, shaping industry trends and expanding opportunities for market players.

Market Size and Overview

The hereditary amyloidosis market is estimated to be valued at USD 1.38 Bn in 2025 and is expected to reach USD 3.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.00% from 2025 to 2032.

https://www.coherentmi.com/ind....ustry-reports/heredi

Cardiac Amyloidosis Market Growth and Revenue Forecast 2026-2033

The cardiac amyloidosis market is witnessing significant advancements driven by increasing prevalence of amyloid-related cardiac disorders and innovation in therapeutic options. Industry dynamics reflect robust research activities and emerging treatment modalities enhancing patient outcomes. This evolving landscape is shaping new market trends and opportunities for key players through strategic expansions and targeted investments.

Market Size and Overview


The Global Cardiac Amyloidosis Market is estimated to be valued at USD 6.51 Bn in 2025 and is expected to reach USD 10.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

https://www.coherentmi.com/ind....ustry-reports/cardia